Copyright
©The Author(s) 2022.
World J Cardiol. Jul 26, 2022; 14(7): 392-402
Published online Jul 26, 2022. doi: 10.4330/wjc.v14.i7.392
Published online Jul 26, 2022. doi: 10.4330/wjc.v14.i7.392
Ref. | Study type | Country of origin | Incidences |
Zhou et al[6], 2020 | Retrospective cohort study | China | Total patients 191. deceased 54 patients (28 had chronic hf exacerbation, i.e., 52%) survived 137 patients (16 had chronic hf exacerbation, i.e., 12%) P < 0.0001 |
Arentz et al[7], 2020 | Case series | United states | Total patients 21. nine patients (42.9%) acute on chronic hf |
Ruan et al[8], 2020 | Multicenter retrospective analysis | China | Total patients 150. death 68 acute on chronic hf 5 (7%) |
Shis et al[9], 2020 | Single-center cohort jan 2020 - feb 2020 | China | Total patients 416. new-onset heart failure 4.1% |
Chen et al[12], 2020 | Retrospective study | China | Total patients 274. acute on chronic hf 1 (< 1%) new-onset hf 21 (7.7%). 1 recovered and 20 died |
Inciardi et al[13], 2020 | Retrospective study | Italy | Total patients 99. acute on chronic hf 21 (21%) |
Diagnostic tools | Likely heart failure | Likely COVID/ARDS |
BNP/NT-Pro BNP and clinical findings | BNP > 100 pg/mL or NT-Pro BNP > 450 pg/mL Signs and symptoms of right and left heart failure | < 450 pg/mL Absence of signs and symptoms of volume overload |
EKG | Abnormal ekg findings of LVH, LAE, Sinus tachycardia, LAD, RAD, AF, PVCs, BBB | Nonspecific findings or symptoms of pulmonary embolism, Right heart strain or myocardial ischemia |
ECHO | Ejection Fraction%, RV dilatation and dysfunction, LV Diastolic dysfunction, LV global systolic dysfunction | Findings of pulmonary arterial hypertension; RV dysfunction, enlargement and abnormal contraction, septal dyskinesia. Acute Cor pulmonale |
CMRI | Establishes ischemic vs nonischemic heart failure, quantification of ventricular function and scar burden | Distinguishes pulmonary vs extrapulmonary causes for acute respiratory distress syndrome |
Management of heart failure |
We should know that the development of heart failure in COVID-19 patients can complicate management and worsen the prognosis; Chronic heart failure patients have adverse outcomes compared to new-onset heart failure patients; GDMT guided medical therapy should be used in heart failure with individualized patient decision making based on hemodynamic status and development of complications; Avoiding over diuresis to prevent kidney injury and hypoperfusion is necessary; Watching for signs of deterioration and shock with early initiation of vasopressors in mixed shock should be practiced; Cardiac arrhythmias and acute myocardial infarction are some major complications to look out for.; Advanced hemodynamic monitoring helps to guide management in these patients; Post-recovery cardiac, pulmonary rehabilitation with psychological support and nutritional interventions is necessary |
- Citation: Sharma M, Jagirdhar GSK, Guntupalli KK, Kashyap R, Surani S. Heart failure in general and cardiac transplant patients with COVID-19. World J Cardiol 2022; 14(7): 392-402
- URL: https://www.wjgnet.com/1949-8462/full/v14/i7/392.htm
- DOI: https://dx.doi.org/10.4330/wjc.v14.i7.392